Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Transfusion Medicine (Oxford, England)|May 7, 1998
Fatal Clostridium perfringens sepsis from a pooled platelet transfusionC P McDonald, S Hartley, K Orchard, et al.
Bone Marrow Transplantation|March 28, 2017
JACIE accreditation for blood and marrow transplantation: past, present and future directions of an international model for healthcare quality improvementJ A Snowden, E McGrath, R F Duarte, et al.
Multiple Sclerosis and Related Disorders|November 10, 2018
Use of coping strategies in multiple sclerosis: Association with demographic and disease-related characteristics<sup>✰</sup>D P Holland, D K Schlüter, C A Young, et al.
The Journal of Infection|January 1, 1997
Disseminated infection due to Cylindrocarpon lichenicola in a patient with acute myeloid leukaemiaE A James, K Orchard, P H McWhinney, et al.
Bone Marrow Transplantation|June 19, 1998
Adoptive immunotherapy for relapse of chronic myeloid leukemia after allogeneic bone marrow transplant: equal efficacy of lymphocytes from sibling and matched unrelated donorsF van Rhee, D Savage, J Blackwell, et al.
Current Research in Translational Medicine|June 18, 2023
Advanced Systemic Mastocytosis with associated haematological neoplasm: Treatment with avapritinib can facilitate successful bridge to allogeneic haematopoietic cell transplantP Sriskandarajah, D P McLornan, C Oni, et al.
The Journal of Infection|November 18, 2022
Joint consensus statement on the vaccination of adult and paediatric haematopoietic stem cell transplant recipients: Prepared on behalf of the British society of blood and marrow transplantation and cellular therapy (BSBMTCT), the Children's cancer and Leukaemia Group (CCLG), and British Infection Association (BIA)Pde Miller, S R Patel, R Skinner, et al.
British Journal of Haematology|September 1, 1996
Intermediate-dose busulphan before autografting for advanced-phase chronic myeloid leukaemiaS A Rule, D G Savage, S G O'Brien, et al.
Bone Marrow Transplantation|May 4, 2010
Allogeneic hematopoietic SCT as treatment option for patients with mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): a consensus conference proposal for a standardized approachJ Halter, Wmm Schüpbach, C Casali, et al.
Bone Marrow Transplantation|November 12, 2013
EBV-associated post-transplant lymphoproliferative disorder following in vivo T-cell-depleted allogeneic transplantation: clinical features, viral load correlates and prognostic factors in the rituximab eraC P Fox, D Burns, A N Parker, et al.
Pageof 3